All Stories

  1. Hypoxia regulates placental angiogenesis via alternatively activated macrophages
  2. Identification of risk for neonatal haemolysis
  3. Heme oxygenase-1 deficiency results in splenic T-cell dysregulation in offspring of mothers exposed to late gestational inflammation
  4. Simultaneously Monitoring Immune Response and Microbial Infections during Pregnancy through Plasma cfRNA Sequencing
  5. Importance of Hemolysis and Its Clinical Detection in Neonates with Hyperbilirubinemia
  6. Risk profiles for haemolytic and nonhaemolytic neonatal jaundice
  7. Association ofHMOX1gene promoter polymorphisms with hyperbilirubinemia in the early neonatal period
  8. Heme oxygenase and the immune system in normal and pathological pregnancies
  9. Evaluation of a new end-tidal carbon monoxide monitor from the bench to the bedside
  10. Protective effect of heme oxygenase induction in ethinylestradiol‐induced cholestasis
  11. Heme oxygenase-1 confers protection and alters T-cell populations in a mouse model of neonatal intestinal inflammation
  12. Bilirubin-induced neurologic dysfunction (BIND)
  13. Neonatal hemolysis and risk of bilirubin-induced neurologic dysfunction
  14. Heme oxygenase-1 in pregnancy and cancer: similarities in cellular invasion, cytoprotection, angiogenesis, and immunomodulation
  15. Neonatal bilirubin binding capacity discerns risk of neurological dysfunction
  16. Effects of light on metalloporphyrin-treated newborn mice
  17. Risks and benefits of comparative effectiveness research in preterm infants: SUPPORT
  18. Heme Oxygenase-1 Promoter Polymorphisms and Neonatal Jaundice
  19. Raltegravir In Vitro Effect on Bilirubin Binding
  20. The effect of hematocrit on the efficacy of phototherapy for neonatal jaundice
  21. Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates: study protocol of a non-inferiority, randomized controlled trial
  22. Intracellular accumulation of bilirubin as a defense mechanism against increased oxidative stress
  23. A deficiency in haem oxygenase-1 induces foetal growth restriction by placental vasculature defects
  24. Effect of light exposure on metalloporphyrin-treated newborn mice
  25. Neonatal phototherapy: choice of device and outcome
  26. Metalloporphyrins – An Update
  27. Pathologic Unconjugated Hyperbilirubinemia, Isoimmunization, Abnormalities of Red Cells and Infections
  28. Effects of Zinc Deuteroporphyrin Bis Glycol on Newborn Mice After Heme Loading
  29. Bilirubin Production and the Risk of Bilirubin Neurotoxicity
  30. Heme Oxygenase-1 Deletion Affects Stress Erythropoiesis
  31. Is phototherapy exposure associated with better or worse outcomes in 501- to 1000-g-birth-weight infants?
  32. Neonatal jaundice and liver disease
  33. Biomedical engineering aspects of neonatal monitoring
  34. Quantitating carbon monoxide production from heme by vascular plant preparations in vitro
  35. Hemolysis and Hyperbilirubinemia in Antiglobulin Positive, Direct ABO Blood Group Heterospecific Neonates
  36. Understanding Neonatal Jaundice: A Perspective on Causation
  37. Metalloporphyrins in the management of neonatal hyperbilirubinemia
  38. Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress
  39. ELEVATED EXHALED CARBON MONOXIDE CONCENTRATION IN HEMOGLOBINOPATHIES AND ITS RELATION TO RED BLOOD CELL TRANSFUSION THERAPY
  40. Dermal Carbon Monoxide Excretion in Neonatal Rats During Light Exposure
  41. Corrigendum to “Effects of sample dilution, peroxidise concentration, and chloride ion on the measurement of unbound bilirubin in premature newborns” [Clinical Biochemistry 40 (2007) 261–267]
  42. Inhibition of heme oxygenase activity in newborn mice by azalanstat
  43. Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection
  44. (TA)n UGT 1A1 Promoter Polymorphism: A Crucial Factor in the Pathophysiology of Jaundice in G-6-PD Deficient Neonates
  45. The role of Bach1 in the induction of heme oxygenase by tin mesoporphyrin
  46. Effects of sample dilution, peroxidase concentration, and chloride ion on the measurement of unbound bilirubin in premature newborns
  47. Expression and Regulation of Heme Oxygenase Isozymes in the Developing Mouse Cortex
  48. Determination of in vivo carbon monoxide production in laboratory animals via exhaled air
  49. Heme Oxygenase-1 Stabilizes the Blood—Spinal Cord Barrier and Limits Oxidative Stress and White Matter Damage in the Acutely Injured Murine Spinal Cord
  50. End-tidal carbon monoxide measurements in infant respiratory distress syndrome
  51. Concentration of Carbon Monoxide (CO) in Postmortem Human Tissues: Effect of Environmental CO Exposure
  52. Systemic Effects of Orally-Administered Zinc and Tin (IV) Metalloporphyrins on Heme Oxygenase Expression in Mice
  53. Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo
  54. Transcutaneous Bilirubinometry: A Noninvasive Tool for Studying Newborn Jaundiced Rats Before and After Exposure to Light
  55. The Effectiveness of Oral Tin Mesoporphyrin Prophylaxis in Reducing Bilirubin Production after an Oral Heme Load in a Transgenic Mouse Model
  56. Apigenin decreases hemin-mediated heme oxygenase-1 induction
  57. Monitoring Age-Related Susceptibility of Young Mice To Oral Salmonella enterica Serovar Typhimurium Infection Using an In Vivo Murine Model
  58. Determination of carbon monoxide (CO) in rodent tissue: Effect of heme administration and environmental CO exposure
  59. Heme Regulation in Traumatic Brain Injury: Relevance to the Adult and Developing Brain
  60. Phototherapy: Current methods and future directions
  61. NICHD Conference on Kernicterus: Research on Prevention of Bilirubin-Induced Brain Injury and Kernicterus: Bench-to-Bedside—Diagnostic Methods and Prevention and Treatment Strategies
  62. Characterization of Coelenterazine Analogs for Measurements of Renilla Luciferase Activity in Live Cells and Living Animals
  63. Effects of Metalloporphyrins on Heme Oxygenase-1 Transcription: Correlative Cell Culture Assays Guide In Vivo Imaging
  64. Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1
  65. Light Emitting Diodes for Phototherapy for the Control of Jaundice
  66. Alternative Metalloporphyrins for the Treatment of Neonatal Jaundice
  67. Prediction of Hyperbilirubinemia in Near-Term and Term Infants
  68. Sources, Sinks, and Measurement of Carbon Monoxide
  69. Carbon monoxide and bilirubin production in neonates
  70. Exhaled carbon monoxide in asthma
  71. Carbon Monoxide in Breath, Blood, and Other Tissues
  72. Concentration of Carbon Monoxide (CO) in Tissue
  73. Carbon Monoxide Production and Upregulation of Heme Oxygenase Activity in Mice after Heme Administration
  74. Transcutaneous Bilirubinometry: A New Tool for Studying Neonatal Jaundiced Rats
  75. Prediction of Hyperbilirubinemia in Healthy Term- and Near-Term Chinese Newborns
  76. In Vivo Efficacy of Light-Emitting Diodes (LEDs) as a Light Source for Phototherapy in Neonatal Jaundiced Rats
  77. Simultaneous production of carbon monoxide and thiobarbituric acid reactive substances in rat tissue preparations by an iron-ascorbate system
  78. Light-Emitting Diodes: A Novel Light Source for Phototherapy
  79. In Vitro Heme Oxygenase Isozyme Activity Inhibition by Metalloporphyrins • 1176
  80. In Vitro Evaluation of The Efficacy and Safety of Light Emitting Diodes (LEDs) for Neonatal Phototherapy † 1175
  81. Simultaneous production of carbon monoxide and thiobarbituric acid reactive substances in rat tissue preparations by an iron-ascorbate system
  82. Fetal hemoglobin of transfused neonates and spectrophotometric measurements of oxyhemoglobin and carboxyhemoglobin
  83. Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells
  84. Prospective Study of Side Effects Associated with the Use of Silver Sulfadiazine in Severely Burned Patients
  85. Hyperbilirubinemia and kernicterus
  86. Extended management following resuscitation
  87. Correlations of clinical, laboratory, imaging, and placental findings as to the timing of asphyxial events